Liposome-mediated cellular delivery of active gp91phox

PLoS ONE

Volumn 2, Issue 9, 2007, Pages

  Marques, Bruno ^a   Liguori, Lavinia ^a   Paclet, Marie Hélène ^a   Villegas Mendéz, Ana ^a   Rothe, Romy ^a   Morel, Françoise ^a   Lenormand, Jean Luc ^a  

^a LABORATOIRE TIMC IMAG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; LIPOSOME; PROTEIN P40; PROTEIN P47; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; CYBB PROTEIN, HUMAN; DIHYDROLIPOAMIDE DEHYDROGENASE; MEMBRANE PROTEIN; PRIMER DNA; PROTEOLIPID; PROTEOLIPOSOMES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL FREE SYSTEM; CELL TRANSPORT; CHRONIC GRANULOMATOUS DISEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEOLIPOSOME; CELL LINE; IMMUNOHISTOCHEMISTRY; METABOLISM; NUCLEOTIDE SEQUENCE;

MAMMALIA;

BASE SEQUENCE; CELL LINE; CELL-FREE SYSTEM; DIHYDROLIPOAMIDE DEHYDROGENASE; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; PROTEOLIPIDS;

EID: 41149111854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000856     Document Type: Article

References (45)

1. Vignais PV (2002) The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59: 1428-1459.
2. Nauseef WM (2004) Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 122: 277-291.
3. Taylor RM, Baniulis D, Buritt JB, Gripentrog JM, Lord CI, et al. (2006) Analysis of human phagocyte flavocytochrome b(558) by mass spectrometry. J Biol Chem 281: 37045-37056.
4. Wallach TM, Segal AW (1997) Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J 321 (Pt 3): 583-585.
5. Mizrahi A, Berdichevsky Y, Ugolev Y, Molshanski-Mor S, Nakash Y, et al. (2006) Assembly of the phagocyte NADPH oxidase complex: chimeric constructs derived from the cytosolic components as tools for exploring structure-function relationships. J Leukoc Biol 79: 881-895.
6. Nisimoto Y, Ogawa H, Miyano K, Tamura M (2004) Activation of the flavoprotein domain of gp91phox upon interaction with N-temiinal p67phox (1210) and the Rac complex. Biochemistty 43: 9567-9575.
7. Parfet MH, Berthier S, Kuhn L, Garin J, Morel F (2007) Regulation of phagocyte NADPH oxidase activity: identification of two cytochrome b558 activation states. Faseb J.
8. Zhu Y, Marchal C, Casbon AJ, Stull ND, von Lohneysen K, et al. (2006) Deletion mutagenesis of p22phox subunit of flavocytochrome b558: Identification of regions critical for gp91phox maturation and NADPH oxidase activity. J Biol Chem.
9. Heyworth PG, Cross AR, Curnutte JT (2003) Chronic granulomatous disease. Curr Opin Immunol 15: 578-584.
10. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, et al. (2006) Correction of X-linked chrome granulomatous disease by gene therapy, augmented by insertional activation of MDSI-EVII, PRDM16 or SETBP1. Nat Med 12: 401-409.
11. Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, et al. (2001) Tumor targeting using anti-her2 immunoliposomes. J Control Release 74: 95-113.
12. Rigaud JL (2002) Membrane proteins: functional and structural studies using reconstituted proteoliposomes and 2-D crystals. Braz J Med Biol Res 35: 753-766.
13. Liguori L, Marques B, Villegas-Mendez A, Rothe R, Lenormand JL (2007) Production of membrane proteins using cell-free expression systems. Expert Rev Proteomics 4: 79-90.
14. Klammt C, Schwarz D, Lohr F, Schneider B, Dotsch V, et al. (2006) Cell-free expression as an emerging technique for the large scale production of integral membrane protein. Febs J 273: 4141-4153.
15. Klammt C, Schwarz D, Eifler N, Engel A, Pielder J, et al. (2007) Cell-free production of G protein-coupled receptors for functional and structural studies. J Struct Biol..
16. Ishihara G, Goto M, Saeki M, Ito K, Hori T, et al. (2005) Exression of G protein coupled receptors in a cell-free translational system using detergents and thioredoxin-fusion vectors. Protein Expr Purif 41: 27-37.
17. Taylor RM, Burritt JB, Baniulis D, Foubert TR, Lord CI, et al. (2004) Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit. J Immunol 173: 7349-7357.
18. Rotrosen D, Yeung CL, Katkin JP (1993) Production of recombinant cytochrome b558 allows reconstitution of the phagocyte NADPH oxidase solely from recombinant proteins. J Biol Chem 268: 14256-14260.
19. Paclet MH, Coleman AW, Burritt J, Morel F (2001) NADPH oxidase of Epstein-Barr-virus immortalized B lymphocytes. Effect of cytochrome b(558) glycosylation. Eur J Biochem 268: 5197-5208.
20. Cross AR, Yarchover JL, Curnutte JT (1994) The superoxide-generating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox. J Biol Chem 269: 21448-21454.
21. Poinas A, Gaillard J, Vignais P, Doussiere J (2002) Exploration of the diaphorase activity of neutrophil NADPH oxidase. Eur J Biochem 269: 1243-1252.
22. Koshkin V, Pick E (1993) Generation of superoxide by purified and relipidated cytochrome b559 in the absence of cytosolic activators. FEBS Lett 327: 57-62.
23. Koshkin V, Pick E (1994) Superoxide production by cytochrome b559. Mechanism of cytosol-independent activation. FEBS Lett 338: 285-289.
24. Rentsendorj A, Xie J, MacVeigh M, Agadjanian H, Bass S, et al. (2006) Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer. Gene Ther 13: 821-836.
25. Baniulis D, Nakano Y, Nauseef WM, Banfi B, Cheng G, et al, (2005) Evaluation of two anti-gp91phox antibodies as immunoprobes for Nox family proteins: mAb 54.1 recognizes recombinant full-length Nox2, Nox3 and the C-terminal domains of Nox1-4 and cross-reacts with GRP 58. Biochim Biophys Acta 1752: 186-196.
26. Grissharnmer R (2006) Understanding recombinant expression of membrane proteins. Curr Opin Biotechnol 17: 337-340.
27. Monne M, Chan KW, Slotboom, DJ, Kunji ER (2005) Functional expression of eukaryotic membrane proteins in Lactococcus lactis. Protein Sci 14: 3048-3056.
28. Niegowski D, Hedren M, Nordlund P, Eshaghi S (2006) A simple strategy towards membrane protein purification and crystallization. Int J Biol Macromol 39: 83-87.
29. Lundstrom K, Wagner R, Reinhart C, Desmyter A, Cherouati N, et al. (2006) Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems. J Struct Funct Genomics 7: 77-91.
30. Jidenko M, Nielsen RC, Sorensen TL, Moller JV, le Maire M, et al. (2005) Crystallization of a mammalian membrane protein overexpressed in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 102: 11687-11691.
31. Berrier C, Park KH, Abes S, Bibonne A, Berton JM, et al. (2004) Cell-free synthesis of a functional ion channel in the absence of a membrane and in the presence of detergent. Biochemistry 43: 12585-12591.
32. Elbaz Y, Steiner-Mordoch S, Danieli T, Schuldiner S (2004) In vitro synthesis of fully functional EmrE, a multidrug transporter, and study of its oligomeric state. Proc Natl Acad Sci U S A 101: 1519-1524.
33. Campion Y, Paclet MH, Jesaitis AJ, Marques B, Grichine A, et al. (2007) New insights into the membrane topology of the phagocyte NADPH oxidase: Characterization of an anti-gp91-phox conformational monoclonal antibody. Biochimie.
34. Berthier S, Paclet MH, Lerouge S, Roux F, Vergnaud S, et al. (2003) Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRPB/MRP14 regulation. J Biol Chem 278: 25499-25508.
35. Pessach I, Shmelzer Z, Leto TL, Dinauer MC, Levy R (2006) The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation. J Leukoc Biol 80: 630-639.
36. Han CH, Nisimoto Y, Lee SH, Kim ET, Lambeth JD (2001) Characterization of the flavoprotein domain of gp91phox which has NADPH diaphorase activity. J Biochem (Tokyo) 129: 513-520.
37. Bedard K, Lardy B, Krause KH (2007) NOX family NADPH oxidases: Not just in mammals. Biochimie.
38. Sarfstein R, Gorzalczany Y, Mizrahi A, Berdichevsky Y, Molshanski-Mor S, et al. (2004) Dual role of Rac in the assembly of NADPH oxidase, tethering to the membrane and activation of p67phox: a study based on mutagenesis of p67phox-Rac1 chimeras. J Biol Chem 279: 16007-16016.
39. Cusi MG, Terrosi C, Savellini GG, Di Genova G, Zurbriggen R, et al. (2004) Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 22: 735-739.
40. Kim A, Yon MO, Oh YK, Ahn WS, Kim CK (1999) Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. Int J Pharm 180: 75-81.
41. Wasan KM, Sivak O, Rosland M, Risovic V, Barett K (2006) Assessing the antifurigal activity, pharmacokinetics, and tissue atribution of amphotericin B following the administration of Abelcet(R) and AmBisome(R) in combination with caspofungin to rats infected with Aspergillus fumigatus. J Pharm Sci.
42. Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, et al. (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436: 568-572.
43. Torchilin VP (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 8: 343-375.
44. Boeckle S, Wagner E (2006) Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. Aaps J 8: E731-712.
45. Li XJ, Fieschi F, Paclet MH, Grunwald D, Campion Y, et al. (2007) Lcu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 81: 238-249.